Mouse Neuro2a tumor cells irradiated and treated with Myc inhibitors and a STING antagonist (BET/JQ1/C-170) undergo similar phenotypic changes to human cancer cell lines and induce potent immune activation of splenocytes. This evidence concerns the gene MYC and cancer.